Advanced Biomed Inc. ADVB
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | 1.53M | 1.90M | 1.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | 1.63M | 2.83M | 1.62M |
| Operating Income | -- | -- | -1.63M | -2.83M | -1.62M |
| Income Before Tax | -- | -- | -1.82M | -3.19M | -1.70M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -- | -1.82 | -3.19 | -1.70 |
| Earnings from Discontinued Operations | -- | -- | -1.56M | -186.40K | -1.56M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -3.38M | -3.38M | -3.26M |
| EBIT | -- | -- | -1.63M | -2.83M | -1.62M |
| EBITDA | -- | -- | -1.39M | -2.60M | -1.34M |
| EPS Basic | -- | -- | -3.27 | -3.27 | -3.17 |
| Normalized Basic EPS | -- | -- | -1.13 | -1.93 | -1.07 |
| EPS Diluted | -- | -- | -3.27 | -3.27 | -3.17 |
| Normalized Diluted EPS | -- | -- | -1.13 | -1.93 | -1.07 |
| Average Basic Shares Outstanding | -- | -- | 4.19M | 4.19M | 4.11M |
| Average Diluted Shares Outstanding | -- | -- | 4.19M | 4.19M | 4.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |